Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 27:13:868751.
doi: 10.3389/fpsyt.2022.868751. eCollection 2022.

Cariprazine's Potential in Improving Social Dysfunction in Patients With Schizophrenia: A Perspective

Petr Morozov  1 , Roman Bekker  2 , Youri Bykov  3
Affiliations

Cariprazine's Potential in Improving Social Dysfunction in Patients With Schizophrenia: A Perspective

Petr Morozov et al. Front Psychiatry. .

Abstract

Social dysfunction is one of the most debilitating aspects of schizophrenia. Treatment of this complex phenomenon, constituted by negative, cognitive, and affective symptoms, has been difficult with the available pharmacological agents, hence it represents an unmet medical need. Cariprazine, a novel, third-generation antipsychotic with a unique mechanism of action has been proven to sufficiently alleviate negative, cognitive, and affective symptoms of schizophrenia. These characteristics make this compound a valid candidate for addressing social dysfunction too. In this perspective, we argue that cariprazine can be viewed as a "socializing drug" that has the ability to improve the patient's functionality and ultimately their quality of life. Data from animal research, clinical trials, an observational study, and patient cases are provided.

Keywords: D3 receptors; antipsychotic; cariprazine; schizophrenia; social dysfunction.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. WHO . WHO | Schizophrenia. Schizophrenia. 2018.
    1. Bleuler E. Dementia Praecox or the Group of Schizophrenias. Translated by Joseph Zinkin. Int Univ Press; (1950)
    1. Galderisi S, Mucci A, Buchanan RW, Arango C. Negative symptoms of schizophrenia: new developments and unanswered research questions. Lancet Psychiatry. (2018) 5:664–77. 10.1016/S2215-0366(18)30050-6 - DOI - PubMed
    1. Bowie CR, Harvey PD. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat. (2006) 2:531–6. 10.2147/nedt.2006.2.4.531 - DOI - PMC - PubMed
    1. Harvey PD, Strassnig M. Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status. World Psychiatry. (2012) 11:73–9. 10.1016/j.wpsyc.2012.05.004 - DOI - PMC - PubMed

LinkOut - more resources